Allorecognition
- PMID: 12099369
Allorecognition
Abstract
Until recently, the vigorous T-cell response via the direct pathway has overshadowed studies involving the indirect pathway. Thus, while the direct pathway has previously been considered to be the main driving force in alloimmune responses, there is an increasing body of data to support a prominent role of the indirect pathway in transplant rejection. Most importantly, the direct antidonor alloresponse diminishes with time after transplantation, possibly due to the tolerogenic effects of alloantigen presentation by the parenchymal cells of the transplant. In contrast, the indirect alloresponse is likely to be permanently active, due to traffic of recipient dendritic cells (DCs) through the graft. The challenge that this poses in the pursuit of clinical transplant tolerance is how to induce tolerance in T cells with indirect allospecificity.
Similar articles
-
Allorecognition.Transfus Clin Biol. 2001 Jun;8(3):318-23. doi: 10.1016/s1246-7820(01)00121-5. Transfus Clin Biol. 2001. PMID: 11499986 Review.
-
Pathways of allorecognition: implications for transplantation tolerance.Transpl Immunol. 2002 Aug;10(2-3):101-8. doi: 10.1016/s0966-3274(02)00055-2. Transpl Immunol. 2002. PMID: 12216939 Review.
-
Direct and indirect antigen recognition: the pathways to allograft immune rejection.Front Biosci. 1999 May 15;4:D476-80. doi: 10.2741/benichou. Front Biosci. 1999. PMID: 10331992 Review.
-
New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance.Curr Opin Immunol. 2004 Oct;16(5):550-7. doi: 10.1016/j.coi.2004.07.011. Curr Opin Immunol. 2004. PMID: 15341998 Review.
-
Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans.Circulation. 1998 Apr 7;97(13):1257-63. doi: 10.1161/01.cir.97.13.1257. Circulation. 1998. PMID: 9570195 Clinical Trial.
Cited by
-
Endoplasmic reticulum stress-mediated apoptosis involved in indirect recognition pathway blockade induces long-term heart allograft survival.J Biomed Biotechnol. 2010;2010:705431. doi: 10.1155/2010/705431. Epub 2010 May 16. J Biomed Biotechnol. 2010. PMID: 20490280 Free PMC article.
-
Evolving concepts and treatment strategies for cardiac allograft vasculopathy.Curr Treat Options Cardiovasc Med. 2014 Jan;16(1):278. doi: 10.1007/s11936-013-0278-x. Curr Treat Options Cardiovasc Med. 2014. PMID: 24346852
-
Immune recognition and rejection of allogeneic skin grafts.Immunotherapy. 2011 Jun;3(6):757-70. doi: 10.2217/imt.11.2. Immunotherapy. 2011. PMID: 21668313 Free PMC article. Review.
-
Donor-Specific Regulatory T Cell-Mediated Immune Tolerance in an Intrahepatic Murine Allogeneic Islet Transplantation Model with Short-Term Anti-CD154 mAb Single Treatment.Cell Transplant. 2020 Jan-Dec;29:963689720913876. doi: 10.1177/0963689720913876. Cell Transplant. 2020. PMID: 32216448 Free PMC article.
-
Composite tissue allotransplantation immunology.Arch Plast Surg. 2013 Mar;40(2):141-53. doi: 10.5999/aps.2013.40.2.141. Epub 2013 Mar 11. Arch Plast Surg. 2013. PMID: 23529264 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources